Connection
John Curtin to Everolimus
This is a "connection" page, showing publications John Curtin has written about Everolimus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.061 |
|
|
|
-
Musa F, Alard A, David-West G, Curtin JP, Blank SV, Schneider RJ. Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer. Mol Cancer Ther. 2016 07; 15(7):1557-67.
Score: 0.033
-
Korets SB, Musa F, Curtin J, Blank SV, Schneider RJ. Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer. Gynecol Oncol. 2014 Feb; 132(2):468-73.
Score: 0.028